期刊名称：CANCER JOURNAL
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
About the Journal
The Cancer Journal: The Journal of Principles & Practice of Oncology provides an integrated view of modern oncology across all disciplines. The Journal publishes original research and reviews, and keeps readers current on content published in the book Cancer: Principles & Practice of Oncology.
Instructions to Authors
The Cancer Journal: The Journal of Principles & Practice of OncologyOnline Submission and Review System
Instructions for Authors (this page)
Copyright Transfer (PDF)
Reprint Ordering
Permissions Requests
Note: These guidelines conform to the 2006 Uniform Requirements for Manuscripts Submitted to Biomedical Journals.¡± The complete document may be accessed at: http://www.ICMJE.org.
Scope. The Cancer Journal: The Journal of Principles & Practice of Oncology provides an integrated view of modern oncology across all disciplines. The Journal publishes original research and reviews, and keeps readers current on content published in the book Cancer: Principles & Practice of Oncology. In addition, readers may submit questions which will be answered in the Journal. Edited by the same team as the classic book, The Cancer Journal is a premier educational resource.
The Cancer Journal is published bimonthly and considers original articles in English relating to all aspects of oncology, including clinical aspects; medical, surgical, and radiation therapies; and research from basic science disciplines that has implications for oncology. The Editors are particularly interested in manuscripts that offer a multidisciplinary approach, discuss new modalities, or emphasize translational research.
Ethical/Legal Considerations. A submitted manuscript must be an original contribution not previously published (except as an abstract or a preliminary report), must not be under consideration for publication elsewhere, and, if accepted, must not be published elsewhere in similar form, in any language, without the consent of Lippincott Williams & Wilkins. Each person listed as an author is expected to have participated in the study to a significant extent. Although the editors and referees make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the Journal, its editors, or the publisher.
Copyright Transfer form and Conflict of Interest Statement: All authors must sign a copy of the Journal's Copyright Transfer¡± form and provide a statement of their institutional or corporate affiliations at the time of manuscript acceptance. The form can be accessed at www.journalppo.com.
Permissions: Authors must submit written permission from the copyright owner (usually the publisher) to use direct quotations, tables, or illustrations that have appeared in copyrighted form elsewhere, along with complete details about the source. Any permissions fees that might be required by the copyright owner are the responsibility of the authors requesting use of the borrowed material, not the responsibility of Lippincott Williams & Wilkins.
Online Manuscript Submission. Manuscripts should be submitted online through the Journal Editorial Website (http://ppo.edmgr.com).
First-time users: Please click the Register button from the main menu and enter the requested information. On successful registration, you will be sent an e-mail indicating your user name and password. Print a copy of this information for future reference. Note: If you have received an e-mail from us with an assigned user ID and password, or if you are a repeat user, do not register again. Just log in. Once you have an assigned ID and password, re-registration is unnecessary, even if your status changes (that is, author, reviewer, or editor).
Authors: Please click the login button from the menu at the top of the page and log in to the system as an Author. Submit your manuscript according to the author instructions. You will be able to track the progress of your manuscript through the system. If you experience any problems, please contact Zia Raven, Managing Editor (zia.raven@yale.edu).
Journal Contents. Please follow guidelines for article length carefully. If accepted articles exceed recommended length, authors will be required to shorten their articles before publication. In addition, the total number of illustrations (sum of tables and figures) may not exceed half of the number of typed text pages minus one. For example, an article with 15 text pages is limited to a total of 7 illustrations and/or tables.
Original Articles: Original articles describing new findings of major importance are invited for submission. Articles should contain no more than 4,000 words of text.
Reviews: Although most reviews are solicited by the Editors, unsolicited reviews will be considered. Reviews should contain no more than 6,000 words of text.
Commentaries: Editorial commentaries are usually solicited by the Editors, but unsolicited editorial commentaries will be considered for publication. Commentaries can discuss any feature of the Journal, including original articles, illustration features, and review articles. Editorials should contain no more than 1,500 words of text.
Letters to the Editors: Letters may comment on work previously published in the Journal or on current topics in oncology. A letter should contain fewer than 500 words of text.
Fast-Track Review. If a study is likely to have an unusual influence on public health, the authors may request that the Editors conduct fast-track review. The Editors will contact the author with a decision within 10 days of submission and will schedule the manuscript for publication when it is accepted. Reviewers¡' comments will not be provided and decisions will be final.
Preparation of Manuscript. Authors should acquaint themselves with and follow closely the instructions for submission of manuscripts. Manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.
Title page: A title page must be submitted as a separate file. Include on the title page 1) complete manuscript title; 2) authors' full names, highest academic degree(s), position/title, and institutional affiliations; (c) name and address for correspondence, including fax number, telephone number, and e-mail address; (d) address for reprints if different from that of corresponding author; (e) the number of figures and tables; and (f) sources of support that require acknowledgment.
The title page must also include disclosure of funding received for this work from any of the following organizations: National Institutes of Health (NIH); Wellcome Trust; Howard Hughes Medical Institute (HHMI); and other(s).
Structured abstract and key words: Abstract must be submitted as a separate file. Limit the abstract to 400 words for reports of original data. A four-part structured abstract is required: 1) Purpose; 2) Methods (or Patients and Methods, Material and Methods, etc.); 3) Results, and 4) Discussion. Authors may substitute "Design" for "Patients and Methods" in review articles. For other manuscripts, include a conventional abstract of no more than 150 words.
Do not use abbreviations, footnotes, statistical significance values, or references in the abstract.
Key Words: Three to 10 key words or short phrases should be added to the abstract page, using terms from the Medical Subject Heading of Index Medicus.
Text: In most cases, the body of the manuscript should begin with an untitled introduction followed by Methods, Results, and Discussion. These headings should match those in the structured abstract. Longer articles may require subheads to clarify their content.
Informed Consent. For experimental investigations of human or animal subjects, the Methodssection should state that an appropriate institutional review board approved the project. For investigators who do not have formal ethics review committees, the Declaration of Helsinki should be followed. For investigations of human subjects, state in the Methods section how informed consent was obtained.
Recombinant DNA Research Guidelines. All manuscripts involving recombinant DNA research must describe the physical and biologic containment procedures practiced, in agreement with the National Institutes of Health Guidelines.
Case Descriptions and Photographs. Authors should include a signed statement of consent to publish all case descriptions and photographs from all persons (parents or legal guardians for minors) who can be identified in such written descriptions and photographs.
Acknowledgments (if any): All sources of support in the form of grants or other significant assistance should be acknowledged. Any potential conflicts of interest that may appear to exist should be disclosed, particularly the presence or absence of any financial interest in any of the products mentioned in the manuscript. If the manuscript has been presented in public as a paper or poster, the name, date, and place of that meeting may be included.
References: References should be numbered consecutively in the order they are mentioned in the text. Identify references in the text by superscript numbers or numbers in parentheses. Journal names should be abbreviated as in Index Medicus. Include the names of all authors when three or fewer; if more than three, list the first three and "et al."
Do not include personal communications and unpublished work in the reference list; if necessary, they should appear in parentheses in text. Authors must obtain written permission from all individuals named as sources of information in personal communications, whether the communications are oral or written. Copies of signed statements of permission should be submitted along with the manuscript. Unpublished work accepted but not published should be designated as in press in the reference list.
Authors are responsible for the accuracy and completeness of their references and for correct text citation.
Examples of Reference Style:
Journal articles
1. Dudley ME, Ngo LT, Westwood J et al. T-cell clones from melanoma patients immunized against an anchor-modified gp100 peptide display discordant effector phenotypes. Cancer J (Boston MA) 2000;6:6977.
Chapters in edited books
2. Marcus R, Couston AM. Water-soluble vitamins: the vitamin B complex and ascorbic acid. In: Gilman AG, Rall TW, Nies AS et al, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics (8th ed). New York: Pergamon Press, 1990:1530-1552.
Books
3. Taliesnik J. The Wrist. New York: Churchill Livingstone, 1985:79¨C82.
Figures: Art should be created/scanned, saved, and submitted as either a TIFF (tagged image file format) or an EPS (encapsulated PostScript) file. PPT (PowerPoint) files will also be accepted. Line art must have a resolution of at least 1200 dpi (dots per inch). Electronic photographs (radiographs, CT scans, etc) and scanned images must have a resolution of at least 300 dpi. If fonts are used in the artwork, they must be converted to paths or outlines or they must be embedded in the files. Color images must be created/scanned, saved, and submitted as CMYK files. If you do not have the capability to create CMYK files, please disregard this step. Indicate in your cover letter that you are unable to produce CMYK files. Please note that artwork generated from office suite programs such CorelDRAW and MS Word and artwork downloaded from the Internet (JPEG or GIF files) cannot be used.
Detailed Figure Instructions: For a step-by-step guide for submitting digital art, please visit http://LWWonline.com. Select "For Authors," then select "Artwork¡± in the menu on the right. Choose "Digital Art Checklist" and "5 Steps for Creating Digital Artwork" for specific guidelines.
Figure legends: Include legends for all figures. They should be brief and specific, and they should appear on a separate manuscript page after the references. Use scale markers in the image for electron micrographs, and indicate the type of stain used. No legends should appear on the figures and titles should be avoided.
Color figures: Authors who submit color figures will receive an estimate of the cost for color reproduction, at a rate of $750 per page of color illustration. A letter will be sent indicating the total cost. If the author declines to accept the costs of color reproduction, the figures will be converted to black and white.
Tables: Create tables using the table creating and editing feature of your word processing software (eg, Word, WordPerfect). Do not use Excel or comparable spreadsheet programs. Cite tables consecutively in the text, and number them in order of their citation. Each table should appear on a separate sheet and should include the table title, appropriate column heads, and explanatory legends (including definitions of any abbreviations used). Do not embed tables within the body of the manuscript.
After Acceptance
Page proofs and corrections: Corresponding authors will receive electronic page proofs to check the copyedited and typeset article before publication. Portable document format (PDF) files of the typeset pages and support documents (eg, reprint order form) will be made available on a secure website. Complete instructions will be provided with the e-mail for downloading and printing the files and for faxing the corrected page proofs to the publisher. It is the author's responsibility to ensure that there are no errors in the proofs. Changes that have been made to conform to journal style will stand if they do not alter the authors' meaning. Only the most critical changes to the accuracy of the content will be made. Changes that are stylistic or are a reworking of previously accepted material will be disallowed. The publisher reserves the right to deny any changes that do not affect the accuracy of the content. Proofs must be checked carefully and corrections faxed within 48 hours of receipt, as requested in the cover letter accompanying the page proofs.
Reprints: An order form for reprints will be sent to the corresponding author. Reprint requests should be returned by either fax (410.528.4434) or mail to the Author Reprint Department, Lippincott Williams & Wilkins, 351 W. Camden Street, Baltimore, MD 21201. Reprints are normally shipped 6 to 8 weeks after publication of the issue in which the article appears. If you have questions, please contact reprints@LWW.com or call 800.341.2258.
Publisher's contact: Fax corrected page proofs and any other related materials to Production Editor, The Cancer Journal: The Journal of Principles & Practice of Oncology, 443.451.8189 or 410.361.8040.
Compliance with NIH and Other Research Funding Agency Accessibility Requirements
A number of research funding agencies now require or request authors to submit the post-print (the article after peer review and acceptance but not the final published article) to a repository that is accessible online by all without charge. As a service to our authors, LWW will identify to the National Library of Medicine (NLM) articles that require deposit and will transmit the post-print of an article based on research funded in whole or in part by the National Institutes of Health, Wellcome Trust, Howard Hughes Medical Institute, or other funding agencies to PubMed Central. The revised Copyright Transfer Agreement provides the mechanism.
MANUSCRIPT CHECKLIST
Submission Letter
Complete manuscript:
TITLE PAGE
STRUCTURED ABSTRACT/KEY WORDS
TEXT
REFERENCES
TABLES
LEGENDS
Digital figures, clearly numbered/labeled
Corresponding author designated (in cover letter and title page)
Patient release(s) and/or permission letters
Acknowledgments listed for grants and support
Copyright Transfer form
Conflict of Interest statement
Editorial Board
Editorial Board
Editors-in-Chief
Vincent T. DeVita, Jr., MD
New Haven, CT
Theodore S. Lawrence, MD, PhD
Ann Arbor, MI
Steven A. Rosenberg, MD, PhD
Bethesda, MD
Editorial Board
Lewis Cantley, PhD
Boston, MA Ronald A. DePinho, MD
Boston, MA Lance A. Liotta, MD, PhD
Manassas, VA
Giorgio Trinchieri, MD
Frederick, MD
Terry A. Van Dyke, PhD
Chapel Hill, NC
Dermatological Oncology
David J. Leffell, MD
New Haven, CT
Epidemiology
Ellen R. Gritz, PhD
Houston, TX
Michael J. Thun, MD, MS
Atlanta, GA Susan Taylor Mayne, PhD
New Haven, CT
Lois B. Travis, MD, ScD
Bethesda, MD Richard M. Simon, DSc
Rockville, MD
Walter C. Willett, MD, PhD
Boston, MA
Medical Oncology
Janet L. Abrahm, MD
Boston, MA
Kenneth C. Anderson, MD
Boston, MA
Joseph S. Bailes, MD
Alexandria, VA
Stephen B. Baylin, MD
Baltimore, MD
George J. Bosl, MD
New York, NY
Stephen A. Cannistra, MD
Boston, MA
David Carbone, MD, PhD
Nashville, TN Richard E. Champlin, MD
Houston, TX
Edward Chu, MD
New Haven, CT
George D. Demetri, MD
Boston, MA
Richard I. Fisher, MD
Rochester, NY
Kathleen M. Foley, MD
New York, NY
Francine M. Foss, MD
New Haven, CT
Patricia A. Ganz, MD
Los Angeles, CA F. Anthony Greco, MD
Nashville, TN
Roy S. Herbst, MD, PhD
Houston, TX
Hagop M. Kantarjian, MD
Houston, TX
Charles L. Loprinzi, MD
Rochester, MN
Leonard B. Saltz, MD
New York, NY
Chris H. Takimoto, MD, PhD, FACP
San Antonio, TX
Pediatric Oncology
David E. Fisher, MD, PhD
Boston, MA Alberto S. Pappo, MD
Houston, TX David G. Poplack, MD
Houston, TX
Surgical Oncology
H. Richard Alexander, MD
Baltimore, MD
Nasser K. Altorki, MD
New York, NY
Gerard M. Doherty, MD
Ann Arbor, MI
Douglas L. Fraker, MD
Philadelphia, PA Michael T. Lotze, MD
Pittsburgh, PA
Monica Morrow, MD
Philadelphia, PA
Peter W. T. Pisters, MD
Houston, TX
Mitchell C. Posner, MD, FACS
Chicago, IL Allan E. Siperstein, MD
Cleveland, OH
Craig L. Slingluff, Jr., MD
Charlottesville, VA
Robert Udelsman, MD
New Haven, CT
Herbert J. Zeh, III, PhD
Pittsburgh, PA
Radiation Oncology
Edgar Ben-Josef, MD
Ann Arbor, MI
Louis S. Constine, MD
Rochester, NY
Laura A. Dawson, MD
Toronto, Ontario
Patricia J. Eifel, MD, FACR
Houston, TX Stephen M. Hahn, MD
Philadelphia, PA
Lawrence B. Marks, MD
Durham, NC
Peter M. Mauch, MD
Boston, MA
Minesh P. Mehta, MD
Madison, WI William M. Mendenhall, MD
Gainesville, FL
Bruce D. Minsky, MD
Chicago, IL
Brian O'Sullivan, MD
Toronto, Ontario
Anthony L. Zietman, MD
Boston, MA
Editorial Board
1528-9117.pdf
| 
